D-0083-2019 Class II Terminated

Recalled by Lannett Company, Inc. — Philadelphia, PA

FDA drug recall D-0083-2019 was initiated by Lannett Company, Inc. on Oct 11, 2018 and is designated Class II. Reason for recall: CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities. The recall status is terminated (terminated Feb 22, 2019). Affected quantity: 8,324 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 31, 2018
Initiation Date
Oct 11, 2018
Termination Date
Feb 22, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,324 bottles

Product description

HydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only, Distributed by Lannett Company, Inc., Philadelphia, PA 19154, NDC 54838-502-80.

Reason for recall

CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.

Distribution pattern

Nationwide in the USA

Code information

Lot #: 1097, Exp 10/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0083-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0083-2019. Report a data issue: hello@regdatalab.com.